Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
sales of 46.58 billion Swiss Francs [US$51.41 billion]
of which 78%
was Innovative Medicines),
of UNITED KINGDOM
(£34.10 billion [US$47.62 billion]
based in GERMANY
(41.40 billion Euros [US$50.18 billion]
of which 46%
Roche Holding Aktiengesellschaft reported sales of 58.32 billion Swiss Francs (US$64.37 billion)
December of 2020.
decrease of 5.1%
versus 2019, when the company's sales were 61.47 billion Swiss Francs.
Contributing to the drop in overall sales was the 8.2% decline
in Pharmaceuticals, from 48.52 billion Swiss Francs to 44.53 billion Swiss Francs.
However, these declines were partially offset by the increase in sales of
Diagnostics (up 6.5% to 13.79 billion Swiss Francs)